Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Huge demand curve for cannbinoid based pharmaceuticals is in
View:
Post by subaru1i on Apr 27, 2024 8:23am

Huge demand curve for cannbinoid based pharmaceuticals is in

the making, 1) April 26 and 2) April 27.    DEA....how a big smooth 'milk' shake to wash down that 'beef' burger.   Enjoy your own ignorance.  


1) What's New
April 26, 2024 
 
The FDA has received additional results from an initial limited set of geographically targeted samples as part of its national commercial milk sampling study underway in coordination with USDA. The FDA continues to analyze this information; however, preliminary results of egg inoculation tests on quantitative polymerase chain reaction (qPCR)-positive retail milk samples show that pasteurization is effective in inactivating HPAI.
 
This additional testing did not detect any live, infectious virus. These results reaffirm our assessment that the commercial milk supply is safe. 
 
In addition, several samples of retail powdered infant formula were tested, as well as powdered milk products marketed as toddler formula. All qPCR results of formula testing were negative, indicating no detection of viral fragments or virus in powdered formula products.
 
The FDA is further assessing retail samples from its study of 297 samples of retail dairy products from 38 states. All samples with a PCR positive result are going through egg inoculation tests, a gold-standard for determining if infectious virus is present. These important efforts are ongoing, and we are committed to sharing additional testing results as soon as possible. Subsequent results will help us to further review our assessment that pasteurization is effective against this virus and the commercial milk supply is safe.
 
Epidemiological signals from our CDC partners continue to show no uptick of human cases of flu and no cases of H5N1, specifically, beyond the one known case related to direct contact with infected cattle.




2) Why dangerous bird flu is spreading faster and farther than first thought in U.S. cattle
Infections could have been 'flying under our radar for months,' researcher says
 
Lauren Pelley, Amina Zafar · CBC News · Posted: Apr 27, 2024 4:00 AM EDT | Last Updated: 4 hours ago

 
A dangerous type of bird flu virus discovered in the lung of a U.S. dairy cow that didn't show symptoms. Viral particles identified in processed, pasteurized milk. Genetic sequences showing distinct changes in this H5N1 strain that's been rapidly spreading throughout American cattle.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities